Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06378580
Status:
COMPLETED
Last Update Posted:
2024-04-22
First Post:
2024-04-17
Brief Title:
The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma
Sponsor:
Luo Cong
Organization:
Zhejiang Cancer Hospital
Organization Data
Organization:
Zhejiang Cancer Hospital
Class:
OTHER
Study ID:
LGF22H160084
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Luo Cong
Lead Sponsor Class:
OTHER
Responsible Party:
Luo Cong
Responsible Party Title:
Director
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Zhejiang Cancer Hospital
Old Name:
None
Old Organization:
None